News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: itsabouttime post# 235700

Sunday, 09/20/2015 2:26:04 PM

Sunday, September 20, 2015 2:26:04 PM

Post# of 347009

I think this was a telling hint " AZN is not in the first pole position" GILD looks to be a good choice.



if AstraZeneca is not in first pole position and AstraZeneca is referring to the deal that they made with Peregrine Pharmaceuticals as "...our partnership", then I wonder what the deal will be referred to with one that is in first pole position ?

CALICO.... you guys hearing this ? : ) better just call SK in the a.m. and conference on UTSWM and Abbvie all while you are at it and all just pony up some Billions of dollars and if you do not, someone else will (Gilead??) : )


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y